Latest News
Learn about a key lifestyle change that could help decrease your risk for developing the devastating eye disease
Learn about an implantable wireless device has identified new ways to help physicians diagnose and monitor glaucoma.
Learn about the first successful attempt to transplant lab-grown retinal ganglion cells (RGCs) into the eyes of mice to find a cure for glaucoma.
Recently, when their groundbreaking genetics discovery was featured on the cover of Nature, the research team thanked BrightFocus for critical early funding that supported their accomplishments.
An interdisciplinary team of Harvard scientists has successfully reprogrammed cells in mice to reverse vision loss from glaucoma, as well as normal (not disease-related) vision loss associated with aging in mouse models.
Learn about a new FDA-approved long-term glaucoma treatment, the benefits and risks of glaucoma surgery, research exploring how pressure in the eye is regulated, risk factors for the development of glaucoma, and more in the fall edition of Natonal Glaucoma Research Report.
BrightFocus Foundation, a premier private funder of vision research, today announced a request for proposals for science projects supported through its National Glaucoma Research program.
Learn about a large, international collaboration that has advanced a scoring approach to be used for weighing glaucoma risk and personalizing treatment.
New models and insights into preventing surgically-induced glaucoma.
